Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1136/bcr-2013-202939 http://scihub22266oqcxt.onion/10.1136/bcr-2013-202939 C3975485!3975485!24671322     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       BMJ+Case+Rep 2014 ; 2014 (ä): ä Nephropedia Template TP {{tp|p=24671322|t=2014. Treating neuromyelitis optica with the interleukin-6 receptor antagonist tocilizumab |pdf=|usr=}}{{24671322}} gab.com Text Treating neuromyelitis optica with the interleukin-6 receptor antagonist tocilizumab JO: BMJ Case Rep http://www.kidney.de/pget.php?&tw=1&pmid=24671322 #FOAvip We present a 32-year-old female patient with fulminant neuromyelitis optica. After the initial treatment with the monoclonal antibody rituximab failed, therapy with the anti-IL-6 receptor antagonist tocilizumab was initiated. The patient experienced a clinically relevant improvement from severe tetraparesis to low-grade paresis, which is still maintained. On MRI of the spinal cord an almost complete restitution of a predescribed extensive myelopathy accompanied this clinical improvement. Meanwhile clinical stability was achieved for over 1?year without any side effects of the ongoing treatment with tocilizumab. Twit Text FOAVip Treating neuromyelitis optica with the interleukin-6 receptor antagonist tocilizumab ????BMJ Case Rep http://www.kidney.de/pget.php?&tw=1&pmid=24671322 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=24671322 #FOAvip English Wikipedia <ref>{{Cite pmid|24671322}}</ref> Treating neuromyelitis optica with the interleukin-6 receptor antagonist tocilizumab #MMPMID24671322 Lauenstein AS; Stettner M; Kieseier BC; Lensch E BMJ Case Rep 2014[]; 2014 (ä): ä PMID24671322show ga We present a 32-year-old female patient with fulminant neuromyelitis optica. After the initial treatment with the monoclonal antibody rituximab failed, therapy with the anti-IL-6 receptor antagonist tocilizumab was initiated. The patient experienced a clinically relevant improvement from severe tetraparesis to low-grade paresis, which is still maintained. On MRI of the spinal cord an almost complete restitution of a predescribed extensive myelopathy accompanied this clinical improvement. Meanwhile clinical stability was achieved for over 1?year without any side effects of the ongoing treatment with tocilizumab. äTreating neuromyelitis optica with the interleukin-6 receptor antagoni(epmc).pdf DeepDyve Pubget Overpricing